Johnson & Johnson COVID-19 vaccine produces strong immune response in early trial
Bengaluru: A single dose of Johnson & Johnson’s experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, according to interim results published on